

Dynamic Medical Reviewer with extensive experience at TATA Consultancy Services, adept in MedDRA coding and SUSAR identification. Proven track record in enhancing patient care through meticulous documentation and compliance. Skilled in patient advocacy and collaboration, ensuring safety across diverse therapeutic areas while driving quality improvements in pharmacovigilance.
I am currently managing Individual Case Safety Reports (ICSR) of Global
Pharmacovigilance department of the client involving duties of:
• Medically confirming accurate coding of reported term against MedDRA.
• Assessing Company Causality and providing Company rationale/remark for the same.
• Confirming the labelling assessment against the Reference Safety Information
(RSI)/other applicable labels.
• Ensuring medically cohesive, consistent case narrative.
• Confirming the correct identification of Suspected Unexpected Serious Adverse
Reactions (SUSARs).
• Writing Analysis of Similar Events (AoSE) for the cases requiring IND
submission.
• Requesting follow-up information and initiating appropriate queries for missing
information
• Identifying potential signals arising from the ICSRs and communicating with
respective stake holders.
• Representing Medical Reviewers during Audits and Inspections.
• Responsible for end-to-end safety of the products in the supply chain which
includes diverse portfolio (Rheumatology, Haematology, neurology, respiratory
medicines, and oncology).
• Actively collaborating with internal & external stakeholders for safety related
activities, tracking safety surveillance of the molecule in collaboration with safety
lead.